Evgeny Shkolnik, MD, FACC

Burneikaitė G, Shkolnik E, Puronaitė R, Zuozienė G, Petrauskienė B, Misonis N, Kazėnaitė E, Laucevičius A, Smih F, Rouet P, Čelutkienė J. The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial Frontiers In Cardiovascular Medicine 2023, 10: 1004574. PMID: 36910537, PMCID: PMC9996196, DOI: 10.3389/fcvm.2023.1004574.

Negishi T, Thavendiranathan P, Penicka M, Lemieux J, Murbraech K, Miyazaki S, Shirazi M, Santoro C, Cho GY, Popescu BA, Kosmala W, Costello B, la Gerche A, Mottram P, Thomas L, Seldrum S, Hristova K, Bansal M, Kurosawa K, Fukuda N, Yamada H, Izumo M, Tajiri K, Sinski M, Vinereanu D, Shkolnik E, Banchs J, Kutty S, Negishi K, Marwick TH. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging 2022 PMID: 36435732, DOI: 10.1016/j.jcmg.2022.10.010.

Jeyashanmugaraja GP, Shkolnik E, Akanya DT, Stawiarski K, Winterbottom C, Zarich S. Corrigendum to : One clot after another in COVID-19 patient: diagnostic utility of handheld echocardiogram Oxford Medical Case Reports 2021, 2021: omab070-. PMID: 34327007, PMCID: PMC8315121, DOI: 10.1093/omcr/omab070.

Čelutkienė J, Burneikaitė G, Shkolnik E, Jakutis G, Vajauskas D, Čerlinskaitė K, Zuozienė G, Petrauskienė B, Puronaitė R, Komiagienė R, Butkuvienė I, Steponėnienė R, Misiūra J, Laucevičius A. The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study. Cardiovascular Ultrasound 2019, 17: 13. PMID: 31272465, PMCID: PMC6610956, DOI: 10.1186/s12947-019-0163-1.

Shkolnik E, Burneikaite G, Jakutis G, Scherbak M, Zuoziene G, Petrauskiene B, Trush E, Vasyuk Y, Laucevicius A, Celutkiene J. A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris. Coronary Artery Disease 2018, 29: 579-586. PMID: 29912782, DOI: 10.1097/MCA.0000000000000648.

Shkolnik E, Burneikaite G, Celutkiene J, Scherbak M, Zuoziene G, Petrauskiene B, Trush E, Laucevicius A, Vasyuk Y. Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study The Anatolian Journal Of Cardiology 2018, 19: 100-109. PMID: 29424731, PMCID: PMC5864803, DOI: 10.14744/anatoljcardiol.2017.8023.

Burneikaitė G, Shkolnik E, Čelutkienė J, Zuozienė G, Butkuvienė I, Petrauskienė B, Šerpytis P, Laucevičius A, Lerman A. Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis Cardiovascular Ultrasound 2017, 15: 11. PMID: 28403861, PMCID: PMC5389112, DOI: 10.1186/s12947-017-0102-y.

Vasyuk YA, Nesvetov VV, SHkolnik EL, Fursov SA, Shkolnik LD, Gendlin GE, Emelina EI. [Possibilities of modern echocardiographic technologies in the early diagnosis of the cardiotoxic effect of chemotherapy drugs anthracycline series in cancer patients]. Kardiologiia 2017, 57: 31-37. PMID: 29466180, DOI: 10.18087/cardio.2417.

Vasyuk YA, Shkolnik EL, Nesterov VV, Shkolnik LD, Varlan GV. [Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity]. Kardiologiia 2016, 56: 72-79. PMID: 28290807.

Vasiuk IuA, Khadzegova AB, Ivanova SV, Iushchuk EN, Shkol'nik EL, Gabitova RG, Sinitsyna IA, Matveeva OS. [Relationship between the structure-functional state of the heart and brain natriuretic peptide level in patients with arterial hypertension]. Kardiologiia 2012, 52: 19-23. PMID: 22839665.

Vasiuk IuA, Shal'nova SA, Shkol'nik EL, Kulikov KG. [The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women]. Kardiologiia 2011, 51: 11-5. PMID: 21878064.

Vasyuk YA, Hadzegova AB, Shkolnik EL, Kopeleva MV, Krikunova OV, Iouchtchouk EN, Aronova EM, Ivanova SV. Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. Congestive Heart Failure (Greenwich, Conn.) 2010, 16: 226-30. PMID: 20887620, DOI: 10.1111/j.1751-7133.2010.00182.x.

Vasiuk IuA, Shkol'nik EL, Lebedev EV. [Possibilities of if channels inhibitor ivabradine in complex treatment of survivors of myocardial infarction with stable angina]. Kardiologiia 2010, 50: 13-8. PMID: 20831042.

Vasiuk YA, Shkol'nik EL, Kudriakov ON, Kulikov KG. [Effect of therapy with trimetazidine modified release on quality of life of patients with stable effort angina survivors after acute myocardial infarction. Results of PRIMA study]. Kardiologiia 2010, 50: 45-9. PMID: 20459421.

Vasiuk IuA, Shal'nova SA, Shkol'nik EL, Kulikov KG. [The PRIMA study: trimetazidin in the treatment of patients with stable angina pectoris after myocardial infarction. Epidemiological and clinical phases]. Kardiologiia 2008, 48: 10-3. PMID: 19076088.

Khadzegova AB, Shkol'nik EL, Kopeleva MV, Iushchuk EN, Lebedev EV, Vasiuk IuA. [Shock-wave therapy: novel direction in the treatment of ischemic heart disease]. Kardiologiia 2007, 47: 90-4. PMID: 18260970.

Vasiuk IuA, Dovzhenko TV, Shkol'nik EL. [Chronic low cardiac output and depression (review)]. Ter Arkh 2007, 79: 54-60. PMID: 18154147.

Vasiuk IuA, Iushchuk EN, Shkol'nik EL, Khadzegova AB, Sadulaeva IA, Vit'ko NK, Vakhromeeva MN. [Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure]. Ter Arkh 2007, 79: 51-8. PMID: 17460970.